13F HOLDINGS REPORT
Artia Global Partners LP
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001937964-26-000002
Total Value
$705.8M
Positions
55
Other Managers
0
Confidential Omitted
No
Holdings (55)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INSMED INC | INSM | 682,212 | $118.7M | 16.82% |
| 2 | ABIVAX SA | AAVXF | 600,747 | $81.0M | 11.48% |
| 3 | INSMED INC | INSM | 420,000 | $73.1M | 10.36% |
| 4 | ARGENX SE | ARGX | 64,699 | $54.4M | 7.71% |
| 5 | ELI LILLY & CO | LLY | 50,500 | $54.3M | 7.69% |
| 6 | VIKING THERAPEUTICS INC | VKTX | 719,365 | $25.3M | 3.59% |
| 7 | TREVI THERAPEUTICS INC | TRVI | 2,013,602 | $25.2M | 3.57% |
| 8 | SOLENO THERAPEUTICS INC | SLNO | 533,698 | $24.7M | 3.50% |
| 9 | PROSHARES TR II | 74347W601 | 442,119 | $24.5M | 3.48% |
| 10 | UNIQURE NV | QURE | 1,023,539 | $24.5M | 3.47% |
| 11 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 503,936 | $17.7M | 2.50% |
| 12 | ASTRAZENECA PLC | AZN | 190,752 | $17.5M | 2.48% |
| 13 | CIDARA THERAPEUTICS INC | 171757206 | 70,824 | $15.6M | 2.22% |
| 14 | EYEPOINT PHARMACEUTICALS INC | EYPT | 767,098 | $14.0M | 1.99% |
| 15 | IONIS PHARMACEUTICALS INC | IONS | 144,376 | $11.4M | 1.62% |
| 16 | DIANTHUS THERAPEUTICS INC | DNTH | 205,090 | $8.5M | 1.20% |
| 17 | REVOLUTION MEDICINES INC | RVMDW | 104,190 | $8.3M | 1.18% |
| 18 | QUEST DIAGNOSTICS INC | DGX | 40,817 | $7.1M | 1.00% |
| 19 | ALNYLAM PHARMACEUTICALS INC | ALNY | 17,400 | $6.9M | 0.98% |
| 20 | VENTYX BIOSCIENCES INC | 92332V107 | 695,982 | $6.3M | 0.89% |
| 21 | PALVELLA THERAPEUTICS INC NE | PVLA | 59,200 | $6.2M | 0.88% |
| 22 | PROSHARES TR II | 74347W601 | 100,000 | $5.6M | 0.79% |
| 23 | MINERALYS THERAPEUTICS INC | MLYS | 137,800 | $5.0M | 0.71% |
| 24 | SIONNA THERAPEUTICS INC | SION | 119,741 | $4.9M | 0.70% |
| 25 | PALISADE BIO INC | PALI | 1,992,367 | $4.7M | 0.66% |
| 26 | AVIDITY BIOSCIENCES INC | 05370A108 | 60,100 | $4.3M | 0.61% |
| 27 | SCHOLAR ROCK HLDG CORP | SRRK | 96,285 | $4.2M | 0.60% |
| 28 | RAPPORT THERAPEUTICS INC | RAPP | 138,508 | $4.2M | 0.60% |
| 29 | PROKIDNEY CORP | PROK | 1,838,411 | $4.1M | 0.58% |
| 30 | ASCENDIS PHARMA A/S | ASND | 17,740 | $3.8M | 0.54% |
| 31 | ABBVIE INC | ABBV | 14,500 | $3.3M | 0.47% |
| 32 | BELITE BIO INC | BLTE | 17,989 | $2.9M | 0.41% |
| 33 | ROIVANT SCIENCES LTD | ROIV | 129,800 | $2.8M | 0.40% |
| 34 | TRAVERE THERAPEUTICS INC | TVTX | 70,700 | $2.7M | 0.38% |
| 35 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 33,407 | $2.6M | 0.37% |
| 36 | UNITED THERAPEUTICS CORP DEL | UTHR | 5,000 | $2.4M | 0.35% |
| 37 | SOLENO THERAPEUTICS INC | SLNO | 50,000 | $2.3M | 0.33% |
| 38 | PROTAGONIST THERAPEUTICS INC | PTGX | 22,951 | $2.0M | 0.28% |
| 39 | UPSTREAM BIO INC | UPB | 68,653 | $1.9M | 0.26% |
| 40 | XENON PHARMACEUTICALS INC | XENE | 40,000 | $1.8M | 0.25% |
| 41 | OCULAR THERAPEUTIX INC | OCUL | 141,061 | $1.7M | 0.24% |
| 42 | BRIDGEBIO PHARMA INC | BBIO | 20,400 | $1.6M | 0.22% |
| 43 | BRIGHTSPRING HEALTH SVCS INC | 10950A106 | 41,600 | $1.6M | 0.22% |
| 44 | PEPGEN INC | PEPG | 205,324 | $1.3M | 0.19% |
| 45 | ABIVAX SA | AAVXF | 9,900 | $1.3M | 0.19% |
| 46 | CELCUITY INC | CELC | 12,900 | $1.3M | 0.18% |
| 47 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 29,200 | $1.2M | 0.17% |
| 48 | OCULAR THERAPEUTIX INC | OCUL | 85,200 | $1.0M | 0.15% |
| 49 | NUVALENT INC | NUVL | 8,100 | $814,779 | 0.12% |
| 50 | AVALO THERAPEUTICS INC | AVTX | 41,570 | $754,911 | 0.11% |
| 51 | PRAXIS PRECISION MEDICINES I | PRAX | 2,500 | $736,850 | 0.10% |
| 52 | ALTO NEUROSCIENCE INC | ANRO | 29,192 | $519,618 | 0.07% |
| 53 | TENAX THERAPEUTICS INC | TENX | 42,080 | $512,955 | 0.07% |
| 54 | KODIAK SCIENCES INC | KOD | 17,019 | $475,851 | 0.07% |
| 55 | LYRA THERAPEUTICS INC | LYRA | 8,756 | $26,968 | 0.00% |